9 results  1 of 1 

1 Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.2023;55(1):245-257.   Published online 2022 July 19     DOI: http://dx.doi.org/10.4143/crt.2022.232
      
2 Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
Aeran Seol, Ga Won Yim, Joo Yeon Chung, Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song
Cancer Res Treat.2022;54(4):1219-1229.   Published online 2021 November 17     DOI: http://dx.doi.org/10.4143/crt.2021.1010
      
3 Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
De-Ying Wang, Na Li, Yu-Lan Cui
Cancer Res Treat.2020;52(3):798-814.   Published online 2020 March 3     DOI: http://dx.doi.org/10.4143/crt.2019.498
      
4 Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
Min Chul Choi, Sohyun Hwang, Sewha Kim, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Tae-Heon Kim, Haeyoun Kang, Hee Jung An
Cancer Res Treat.2020;52(2):634-644.   Published online 2020 January 6     DOI: http://dx.doi.org/10.4143/crt.2019.207
      
5 The Ability of Preoperative Serum CA-125 level to Predict the Outcome of Primary Cytoreductive Surgery of Epithelial Ovarian Carcinoma
Han Moie Park, Yoon Soo Kim, Eun Kyoung Shin, Mi Kyoung Kim, Kyung Ah Jung, Mi Hye Park, Sun Hee Chun, Jung Ja Ahn, Chong Il Kim, Seung Cheol Kim
Korean J Gynecol Oncol Colposc.2003;14(2):158-166.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgoc.2003.14.2.158
      
6 Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
Ji Hui Choi, Geum Seon Sohn, Doo Byung Chay, Han Byoul Cho, Jae-Hoon Kim
Obstet Gynecol Sci.2018;61(3):344-351.   Published online 2018 May 2     DOI: http://dx.doi.org/10.5468/ogs.2018.61.3.344
      
7 Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan
Ying-Cheng Chiang, Chi-An Chen, Chun-Ju Chiang, Tsui-Hsia Hsu, Ming-Chieh Lin, San-Lin You, Wen-Fang Cheng, Mei-Shu Lai
J Gynecol Oncol.2013;24(4):342-351.   Published online 2013 October 2     DOI: http://dx.doi.org/10.3802/jgo.2013.24.4.342
      
8 Uterine metastases in ovarian carcinoma: frequency and survival in women who underwent hysterectomy
Joseph Menczer, Angela Chetrit, Siegal Sadetzki,
J Gynecol Oncol.2010;21(3):191-195.   Published online 2010 September 28     DOI: http://dx.doi.org/10.3802/jgo.2010.21.3.191
      
9 Epithelial Ovarian Carcinoma: Analysis of Prognostic Factors
Soo-Nyung Kim, Tchan-Kyu Park
Yonsei Med J.1988;29(3):244-251.   Published online 2002 February 20     DOI: http://dx.doi.org/10.3349/ymj.1988.29.3.244
      

 1 of 1